ArticleKidney international reports2026

Randomized Controlled Trial of Dapagliflozin for Post-Transplant Diabetes Mellitus in Renal Transplant Recipients.

Lu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.